Peloton raises a monster $150M in latest round, as lead drug heads for pivotal trial
Less than two years after raising $22 million in a D round, Dallas-based Peloton Therapeutics has reaped a fresh $150 million E round, eclipsing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
